Prev Close | 0.00 |
Day Low/High | 0.00 / 0.00 |
52 Wk Low/High | 0.00 / 0.00 |
Prev Close | 0.00 |
Day Low/High | 0.00 / 0.00 |
52 Wk Low/High | 0.00 / 0.00 |
Exchange | NYSE |
Div & Yield | N.A. (N.A) |
AVP on market close. If anyone out there is long Avon Products (AVP), there are 1.6 million shares to sell on the close.
The valuation is very attractive but the challenges are daunting.
Indices are mixed and just off flat. By Bret Jensen The market continues its slow melt-up even as indices are mixed and just off flat. I did some bull put spreads on Avon Products (AVP). The stock has technical support about 5% below current levels...
Hologic, Symantec and TE Connectivity could all benefit from the current M&A binge.
Spice up your portfolio with some takeover bait.
Clorox and Avon are candidates for the extremes.
The vast bulk of S&P 500 outlooks are undershooting consensus.
A great company does not always make for a rational investment.
What surprises might occur in 2014 -- and how can we profit?
What surprises might occur in 2014 -- and how can we profit? "Never make predictions, especially about the future." -- Casey Stengel It's that time of the year again! By means of background and for those new to Real Money Pro, 11 years ago, I set ou...
Here are some lowlights of the year that was.
Avon faces significant problems and is likely facing a two to four year turnaround.
These two retail underperformers look likely to climb next year.
Avon Gets Dinged, Endo's Irish Eyes, Piper Pipes Down, Bye-Bye BlackBerry and Walmart Gone Wild highlight Gregg Greenberg's list this week.
Let's apply the 3-Day Rule.
Markets were mixed amid variable earnings results, with growing uncertainty around the wind-down of bond purchases.
This business is undergoing a turnaround at the peak of maximum pessimism.
Here are the rest of the stocks on my 'serial-disappointer' list.
These companies just never seem to deliver, no matter what -- yet those who run them actually think they are doing a good job.
Should you answer?
Zynga and Zale both warrant a healthy dose of caution at the moment.
You're better off with a third direct-selling name.